FAYETTEVILE, N.C. (WTVD) -- Fayetteville native John Rowell calls the FDA's approval of the first injectable treatment for HIV pre-exposure prevention, PrEP, "monumental." The FDA said the injectable ...

According to UNAIDS, in 2024, about 40.8 million people around the world were living with the human immunodeficiency virus (HIV) — a virus that can lead to acquired immunodeficiency syndrome (AIDS) if ...

Nigerians have begun scrambling for Lenacapavir, a newly introduced injection for the prevention of Human Immunodeficiency ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A once-daily pill named PrEP, or pre-exposure prophylaxis, has been a stalwart ...

The CDC made a strong recommendation based on a high certainty of evidence to use the long-acting injectable lenacapavir (Yeztugo) for HIV pre-exposure prophylaxis (PrEP), but will that ensure the ...

Patients are already receiving the new PrEP injectable option lenacapavir in the Bay Area, though issues with insurance are complicating the process of getting shots. The new injectable was approved ...

Add Yahoo as a preferred source to see more of our stories on Google. a group of fit men in blue and white outfits promote national prep day Today is the first National PrEP Day — a new annual event ...

A recent study of injectable pre-exposure prophylaxis found that twice-yearly injections of lenacapavir — marketed as Yeztugo by Gilead Sciences — do not have clinically significant interactions with ...

In a landmark move to strengthen the fight against HIV/AIDS, the Federal Government has introduced Lenacapavir, a long-acting ...

The federal government has commenced the rollout of a new long-acting injectable drug (lenacapavir) for the prevention of HIV infection.

The rollout, which will begin in eight states - Anambra, Ebonyi, Gombe, Kwara, Akwa Ibom, Cross River, Benue, and the Federal ...